A study funded by the NIH found that adults with opioid use disorder (OUD) who take higher doses of buprenorphine, an opioid addiction treatment medication, have a lower risk of emergency department or inpatient visits related to behavioral...
Background: Limited research has been conducted on lifetime trauma exposure among individuals undergoing medication treatment for opioid use disorder (MOUD). A multisite study provided an opportunity to investigate the prevalence of...
Proposals are now being accepted for the 2024 Police, Treatment, and Community Collaborative (PTACC) International Deflection and Pre-arrest Diversion Summit. All submissions must be uploaded by April 19, 2024 at 12:00 PM PDT in order to be...
Read key findings from the 2022 National Survey on Drug Use and Health (NSDUH). This report highlights 2022 statistics on substance use, mental health, and treatment in the United States. These national indicators are measured...
Abstract
Importance Medication for opioid use disorder (MOUD) (eg, buprenorphine and naltrexone) can be offered in primary care, but barriers to implementation exist.
Objective To evaluate an implementation intervention over 2 years to...
Discussion
Despite guidelines recommending MOUD, approximately 1 in 5 adults with past-year OUD received any MOUD. Furthermore, some groups were substantially less likely to receive MOUD, in particular Black adults, women, those unemployed...
In this research, the authors explored how lesbian, gay, bisexual, transgender, and queer (LGBTQ) young adults with problematic substance use made sense of their substance use in relation to their LGBTQ identities.
The authors interviewed...
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Alcohol use disorders (AUD) are prevalent and often go untreated. Patients are commonly screened for AUD in primary care, but existing treatment programs are failing to meet demand. Digital therapeutics include novel...
Il blog è una ricca fonte di apprendimento.
Puoi leggere le informazioni al tuo ritmo.
Condividere con i clienti e le loro famiglie per dotarsi di semplici strategie per fare passi avanti verso un maggiore recupero e meno ricadute.
Qui-...
Un breve intervento con il supporto del coach di recupero tra pari è stato utilizzato per generare rinvii al trattamento del disturbo da uso di sostanze dal dipartimento di emergenza (DE). Questo studio retrospettivo...
L'Evidence-Based Practice Attitudes Scale (EBPAS) è ampiamente utilizzata nella ricerca sull'implementazione, ma non è stata adattata e convalidata per l'uso tra gli insegnanti di istruzione generale, che hanno maggiori...
